(S)-Linezolid Amine Intermediate: Properties & Lab Use
(S)-Linezolid Amine Intermediate: Properties & Lab Use
(S)-5-(Aminomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one is a chiral oxazolidinone pharmaceutical intermediate that serves as a pivotal building block in the synthesis of linezolid-class antibacterial agents and related oxazolidinone derivatives.
- IUPAC Name
- (S)-5-(Aminomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one
- SKU
- S191447
- Core Scaffold
- (S)-Oxazolidin-2-one with a 3-fluoro-4-morpholinophenyl N-substituent
- Stereochemistry
- S-configuration at C-5; single enantiomer
- Key Functional Groups
- Primary amine (–CH₂NH₂), oxazolidinone carbonyl, aryl fluoride, morpholine ring
- Primary Application
- Intermediate in linezolid and oxazolidinone antibiotic synthesis
Chemical Identity and Structure
(S)-5-(Aminomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one is a small-molecule chiral intermediate built around a five-membered oxazolidin-2-one ring. The (S)-configuration at the C-5 position is essential for biological activity in downstream targets, mirroring the stereochemical requirement found in clinically approved oxazolidinone antibiotics such as linezolid.
The N-3 aryl substituent carries both a fluorine atom at the 3-position and a morpholine ring at the 4-position of the phenyl group. These two substituents are pharmacophoric elements widely recognized in oxazolidinone antibacterial design: the ortho-fluorine improves binding geometry within the ribosomal active site, while the morpholine moiety modulates solubility, metabolic stability, and tissue distribution of drug candidates derived from this scaffold.
The C-5 aminomethyl group (–CH₂NH₂) serves as the principal handle for further elaboration. Acylation, sulfonylation, reductive amination, and heterocycle-forming reactions at this primary amine are the most common transformations used to convert this intermediate into biologically active final compounds.
Role in Oxazolidinone Antibiotic Synthesis
This compound is recognized in the medicinal chemistry literature as a direct precursor to linezolid and structurally related oxazolidinone antibacterials. Linezolid, the first member of the oxazolidinone class to reach clinical approval, inhibits bacterial protein synthesis by binding to the 23S ribosomal RNA of the 50S subunit, thereby preventing formation of the 70S initiation complex. The correct (S)-stereochemistry of the oxazolidinone ring is indispensable for this mechanism of action.
In a representative synthetic route, the free amine of this intermediate is acylated with an activated acetamide equivalent to install the acetamidomethyl side chain found in linezolid. Researchers working on next-generation oxazolidinones—including compounds targeting linezolid-resistant strains—also use this scaffold as a starting point for N-acyl, N-sulfonyl, or heterocyclic modifications that modulate spectrum and potency.
The morpholine ring distinguishes this intermediate from earlier oxazolidinone analogs and is retained in clinically deployed molecules because of its favorable pharmacokinetic profile. Its presence also makes the compound a useful probe in structure–activity relationship (SAR) studies exploring variations around the C-5 amine.
Handling, Storage, and Laboratory Safety
As a primary arylamine-containing intermediate, (S)-5-(Aminomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one should be handled under standard laboratory precautions appropriate for reactive amine compounds. Use appropriate personal protective equipment (PPE) including nitrile gloves, safety glasses, and a laboratory coat. Work in a well-ventilated fume hood when weighing or dissolving the material.
The compound should be stored in a tightly sealed container, protected from moisture and light, at the temperature specified on the product certificate of analysis. The free amine functionality may be susceptible to oxidation and carbamation (reaction with atmospheric CO₂); therefore, storage under an inert atmosphere (nitrogen or argon) is recommended for long-term preservation of quality.
For solution preparation, common polar aprotic solvents such as DMF, DMSO, and acetonitrile are generally suitable for dissolving oxazolidinone intermediates of this type. Aqueous buffers at mildly acidic pH can also be used to protonate the amine and improve water solubility. Always consult the current Safety Data Sheet (SDS) supplied by Aladdin Scientific before use.
Analytical Characterization and Quality Considerations
Researchers should verify the identity and purity of this intermediate before use in sensitive synthetic or biological assays. Key analytical techniques include:
- ¹H and ¹³C NMR spectroscopy: Confirms the oxazolidinone ring protons, the diastereotopic CH₂ protons adjacent to nitrogen, the aminomethyl protons at C-5, and the aromatic substitution pattern expected for a 3-fluoro-4-morpholinophenyl group.
- ¹⁹F NMR: Provides a diagnostic signal for the aryl fluorine, useful for confirming correct regiochemistry and absence of defluorinated impurities.
- Chiral HPLC: Critical for confirming enantiomeric excess (ee) of the (S)-enantiomer; any racemization during storage or handling would directly compromise the stereochemical integrity required for downstream synthesis.
- High-resolution mass spectrometry (HRMS): Confirms the exact molecular formula.
- Karl Fischer titration: Recommended if moisture sensitivity is a concern, particularly before use in anhydrous reactions.
Aladdin Scientific's product certificate of analysis (CoA) provides lot-specific data including purity by HPLC and other quality metrics. Researchers should request the CoA for each lot received.
Frequently asked questions
What is the primary synthetic use of (S)-5-(Aminomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one?
This compound is primarily used as a key chiral intermediate in the synthesis of linezolid and related oxazolidinone-class antibacterial agents. The free primary amine at C-5 is the principal reactive site, allowing acylation, sulfonylation, and other transformations to install the side chains present in bioactive final compounds.
Why is the (S)-configuration at C-5 important for this intermediate?
The (S)-configuration at C-5 of the oxazolidinone ring is essential for the biological activity of oxazolidinone antibiotics. The correct stereochemistry ensures optimal spatial orientation of the pharmacophore within the bacterial ribosomal binding site. Using the racemic mixture or the (R)-enantiomer results in significantly diminished antibacterial activity in downstream compounds.
How should this compound be stored to maintain its quality?
The compound should be stored in a tightly sealed container at the temperature indicated on the Aladdin Scientific certificate of analysis, protected from moisture, light, and air. Storage under an inert atmosphere (nitrogen or argon) is recommended to prevent oxidation or carbamation of the primary amine group over time.
What solvents are suitable for dissolving this intermediate in the laboratory?
Polar aprotic solvents such as DMF, DMSO, and acetonitrile are generally suitable. For aqueous applications, mildly acidic buffers can improve solubility by protonating the amine. Solvent selection should be guided by the requirements of the downstream reaction and verified experimentally for each application.
How can I confirm the enantiomeric purity of this compound upon receipt?
Chiral HPLC is the standard method for confirming the enantiomeric excess (ee) of the (S)-enantiomer. Aladdin Scientific provides a certificate of analysis (CoA) with each lot; researchers should review the CoA and may additionally perform in-house chiral HPLC analysis using an appropriate chiral stationary phase column if their application demands independent verification.
References
- Diekema, D.J.; Jones, R.N. Oxazolidinones: A Review. Drugs 2000, 59, 7–16.
- Brickner, S.J. et al. Synthesis and Antibacterial Activity of U-100592 and U-100766, Two Oxazolidinone Antibacterial Agents for the Potential Treatment of Multidrug-Resistant Gram-Positive Bacterial Infections. J. Med. Chem. 1996, 39, 673–679.
- Leach, K.L. et al. The Site of Action of Oxazolidinone Antibiotics in Living Bacteria and in Human Mitochondria. Mol. Cell 2007, 26, 393–402.
Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
危险品化学品经营许可证(带存储)